Second company joins race to produce cardiac laser
This article was originally published in Clinica
Executive Summary
Less than two weeks after an FDA advisory panel finally backed a technique known as transmyocardial revascularisation (TMR), a second manufacturer has begun its bid for US approval of its technology for performing the cardiac procedure.